Programme

(Preliminary)

Wednesday June 11th - Presymposium

08:30 - 09:45	Registration for presymposium and entire congress
09:45 - 10:00	Welcome \| Dr. Ivar A. Eide, Akershus University Hospital
10:00 - 11:00	Norway Chairs: Dr. Ruth Strømmen, Oslo and Nanna von der Lippe, Oslo 1. Amyloidosis in a nephrological perspective \| Dr. Tale Wien, Bærum 2. Who is the patient with amyloidosis? Characteristics and epidemiology \| Dr. Hilde Vasstrand, Bærum 3. AA-amyloidosis in peaople who inject drugs \| Dr. Helga Gudmundsdottir, Oslo
11:00 - 11:10	Break
11:10 - 12:10	Denmark CVD in CKD Chairs: Dr. Joe Chan, Oslo and Dr. Maria Radtke, Trondheim *Epidemiology of cardiovascular disease in CKD* \| Ellen Linnea Freese Ballegaard, Copenhagen University Hospital *CKD and cardiac arrythmias* \| Jesper Mosgaard Rantanen, University of Aalborg *Atherosclerotic renovascular disease* \| Mark Reinhard, University of Aarhus
12:10 - 12:20	Break
12:20 - 13:20	Sweden Different aspects on contributing mechanisms in ANCA-associated vasculitis Chairs: Dr. Marius Øvrehus and Dr. Inga Strand Thorsen, Stavanger *Genetics in ANCA-associated vasculitis* \| Johanna Dahlqvist, Uppsala University Hospital *Complement and complement inhibition at different levels in ANCA-associated vasculitis* \| Sophie Ohlsson, Lund University
13:20 - 14:50	Lunch break
13:45 - 14:45	Lunch symposium - sponsored by Novo Nordisk (Gold sponsor) Metabolic and Renal Interplay: Exploring Obesity, Diabetes, and Chronic Kidney Disease - Welcome and introduction \| Professor Trond Geir Jenssen - The interconnection between obesity, diabetes and chronic kidney disease \| Nephrologist Espen Nordheim - *GLP-1 Receptor Agonists in management of Chronic Kidney Disease* \| Professor Bård Waldum-Grevbo - *Closing* \| Professor Trond Geir Jenssen
14:50 - 15:50	Iceland Chairs: Dr. Anupam Chandra, Oslo and Dr. Sadollah Abedini, Tønsberg 1. Incidence and outcome of community acquired acute kidney injury \| Telma H. Ragnarsdóttir 2. Why do Icelandic dialysis patients have worse survival than other European dialysis patients \| Haraldur O. Arnarsson 3. Can you prevent progression of chronic kidney disease in patients using lithium by stopping lithium treatment? \| Gísli .......Gíslason
15:50 - 16:00	Break
16:00 - 17:00	Finland Chairs: Dr. Tommy Aronsen, Drammen og Dr. Espen Nordheim, Oslo *Update on primary aldosteronism* \| Pasi Nevalainen, Tampere University Hospital *CKD and frailty* \| Tapio Hellman, Turku University Hospital *Home dialysis and patient outcomes* \| Wisam Bitar, Helsinki University Hospital
17:00 - 17:20	Break
17:20 - 18:00	NorTrials / Trial Nation Open Nordic Meeting \| Rikke Borg, Roskilde University Hospital and Peder Myhre, Oslo University Hospital
18:00 - 18:10	NSN Congress Opening \| Dr. Ivar A. Eide, Akershus University Hospital Short presentation of our silver sponsors: Chiesi, Sanofi and Takeda.
18:10- 18:30	Best abstract 1: VALIANT: Randomized, multicenter, double-blind, placebo-controlled, phase 3 trial of pegcetacoplan for patients with native or post-transplant recurrent C3G or primary (idiopathic) IC-MPGN \| Dr. Kati Kaartinen, Helsinki

Thursday June 12th - Congress

08:30 - 09:30	Expert panel discussion: Early CKD detection, prevention and referral \| Prof. Bård Waldum-Grevbo, Oslo, Prof. Maria Eriksson Svensson, Uppsala and Ass. prof. Rikke Borg, Copenhagen
09:30 - 09:45	Break
09:45 - 10:45	Chairs: Dr. Marit Dahl Solbu, Tromsø and Dr. Lene V. Halvorsen, Oslo *Antihypertensive treatment in CKD* \| Docent Daniel Gordin, Helsinki Hypertension in peripartum \| Prof. Jana Brguljan Hitij, Ljubljana
10:45 - 11:00	Break
11:00 - 12:05	Chairs: Dr. Helga Gudmundsdottir, Oslo and Dr. Heidi Ytredal, Ålesund State of the art 1 Quality of life for elderly on dialysis therapy \| Prof. Edwina Brown, London
12:05 - 12:30	Break
12:30 - 13:30	Lunch symposium - sponsored by Vantive (Platinum sponsor) Extending Lives Expanding Possibilities PD cases: You decide - Experts guide. Chair: Dr. Helga Gudmundsdottir, Oslo Introduction: PD care across the Nordics \| Helga Gudmundsdottir, nephrologist at OUS, Ullevål, Norway Assisted PD in clinical practice \| Ulrika Hahn Lundström, nephrologist at Karolinska, Rosenlund, Sweden RM-APD: clinical evidence and utilization \| Tommy Aronson, nephrologist at Vestre Viken, Drammen, Norway PD perspective – patient experience \| Jorn Prinse, Patient from Ullevål, Norway
13:30 - 13:40	Break
13:40 - 14:40	Chairs: Dr. Lene Heramb, Trondheim and Ulrika Hahn Lundström, Stockholm *Debunking the myths of PD* \| Dr. Stig Arne Kjellevold, Tønsberg *Maintaining a high prevalence of patients in PD* \| Dr. Helga Gudmundsdottir, Oslo Technological Innovation in PD \| Dr. Richard Corbett, London
14:40 - 14:50	Break
14:50 - 16:05	Poster Session List of posters: click here
16:05 - 16:30	Break
16:30 - 17:30	Industry symposium sponsored by Astra Zeneca (Platinum Sponsor) Transforming Care Together: A Multidisciplinary Approach to the CardioRenal-metabolic syndrome. Welcome and Introduction \| Dr. Ivar A. Eide • Overview of GDMT (Guideline-Directed Medical Therapy) • Current Implementation Status in the Nordic Countries *The CVRM Triangle: Focus on the CKM Syndrome* \| Muthiah Vaduganathan, cardiologist at Brigham and Women’s Hospital and faculty at Harvard Medical School • SGLT2 Inhibitors and Renal Mechanisms • Hypertension as a Central Risk Factor *Addressing Barriers to GDMT in CKD* \| Prof. Bård Endre Waldum-Grevbo • RAAS blockade and the role of potassium binders
17:30 - 17:40	Break
17:40 - 18:00	*Best abstract 2: Effects of valsartan vs amlodipine and achived lower blood pressure on the insidence of end-stage kidney disease: The VALUE Trial* \|** Prof.emeritus Sverre Kjeldsen, Oslo
19:00 - 21:00	Get Together Oslo City Hall (Rådhuset)

Friday June 13th - Congress

08:30 - 09:15	Chairs: Prof. Ilkka Helanterä and Prof. Kristian Heldal Pro’s and Con’s of Cardiovascular Screening before Kidney Transplantation \| Assoc. Prof. Simon Winther, Aarhus Cardiorenal Prophylaxis After Kidney Transplantation \| Prof. Trond Jenssen, Oslo
09:15 - 09:30	Break
09:30 - 10:45	Chairs: Prof. Susanne Dam Poulsen and Dr. Karsten Midtvedt *Vaccination of Solid Organ Transplant Candidates and Recipients – Experiences from a Structured Vaccination Clinic* \| Prof. Susanne Dam Poulsen, Copenhagen New Guidelines and New Treatments – Update on CMV and BKV after Kidney Transplantation \| Prof. Ilkka Helanterä, Helsinki Coping with EBV and Risk of PTLD - Recent Insights \| Dr. Lene Ugilt Pagter Ludvigsen, Aarhus
10:45 - 11:10	Break
11:10 - 12:00	Chairs: Prof. Trond Jenssen and Prof. Kåre Birkeland State of the art 2 and plenary discussion *State-of-the-Art for Beta-Cell Replacement in Type 1 Diabetes: Stem Cell-Derived Islets and/or Gene-Modified Islet Cells Without the Need for Immunosuppression* \| Prof. Per Ola Carlsson, Uppsala
12:00 - 12:30	Break
12:30 - 13:30	Lunch symposium - sponsored by CSL Vifor (Platinum sponsor) *What is the role of the alternative complement pathway in ANCA-associated vasculitis?* \| Associate professor Sophie Ohlsson, Skånes University Hospital, Lund CKD-aP in hemodialysis: Understanding the itch and optimizing treatment \| Chief physician Associate professor, PhD Jesper Elberling, Herlev and Gentofte Hospital, Copenhagen
13:30 - 13:40	Break
13:40 - 14:40	Chairs: Dr. Inga Strand Thorsen, Stavanger and Dr. Ruth Strømmen, Oslo *CKD MBD: The spectrum of bone diseases in chronic kidney disease* \| Assoc. Prof. Hanne Mari Skov Jørgensen, Aarhus CKD MBD: Preventing fractures in patients with CKD \| Prof. Syazrah Salam, Sheffield
14:40 - 14:50	Break
14:50 - 16:05	Poster Session List of posters: click here
16:05 - 16:30	Break
16:30 - 17:30	Industry symposium - sponsored by Boehringer Ingelheim (Gold Sponsor) *Expanding the Range of Kidney Protection by SGLT2 Inhibitors* \| Assoc. Prof. Beatriz Fernández, Director of the Diabetic Kidney Disease Clinic (FUndación Jimenez Díaz UNiversity Hospital) and Associate Professor in Medicine at the Universidad Autónoma de Madrid Chair: Ivar A Eide, Akershus University Hospital
17:30 - 17:40	Break
17:40 - 18:00	*Best abstract 3: Epstein-Barr Virus Infection moniToring in renAl transplant recipients (EVITA study) - Investigating the clinical significance of EBV-DNAemia and the risk of early-onset PTLD* \|** Dr. Lene Ugilt Pagter Ludvigsen, Aarhus
19:00 -	Congress dinner

Saturday June 14th - Congress

09:00 - 10:30	Chairs: Dr. Thomas Knoop, Bergen and Prof. Øystein Eikrem, Bergen State of the art 3 and plenary discussion *Immunosuppressive therapy in IgA nephritis* \| Prof. Jonathan Barratt, Leicester and Dr.Yngvar Haaskjold, Trondheim *Setting the Scene and Current Goals in IgA Nephropathy* \| Prof. Jonathan Barratt, Leicester *Prognostic Models in IgA Nephropathy* \| Dr. Yngvar Haaskjold, Trondheim *Immunosuppressive Treatments in IgA Nephropathy: When, Which, and Duration?* \| Prof. Jonathan Barratt, Leicester *IgA Vasculitis: Similarities and Contrasts with IgA Nephropathy* \| Prof. Jonathan Barratt, Leicester Discussion \| Prof. Jonathan Barratt, Leicester
10:30 - 10:40	Break
10:40 - 11:50	Chairs: Dr Thomas Knoop, Bergen and Dr. Benedicte Rønning, Oslo *Advanced molecular profiling of FFPE kidney tissues* \| Prof. Øystein Eikrem, Bergen *MPGN and C3* \| Dr. Kati Kaartinen, Helsinki CAR-T cell theraphy in immune-mediated kidney diseases: future prospects an safety \| Dr. Yngvar Haaskjold, Trondheim
11:50- 12:05	Break
12:05 - 13:05	Lunch symposium - sponsored by Medice Nordic (Gold sponsor) Vadadustat INNO2VATIVE anaemia management for dialysis patients \| Dr. Med Patrick Biggar (GE) and Prof. Philip Kalra (UK)
13:05 - 13:15	Congress conclusion